Body size and risk for colorectal cancers showing BRAF mutations or microsatellite instability: A pooled analysis

International Journal of Epidemiology

Volumn 41, Issue 4, 2012, Pages 1060-1072

  Hughes, Laura A E ^a   Williamson, Elizabeth J ^b   Van Engeland, Manon ^a   Jenkins, Mark A ^b   Giles, Graham G ^b,c   Hopper, John L ^b   Southey, Melissa C ^b   Young, Joanne P ^d,e   Buchanan, Daniel D ^d   Walsh, Michael D ^d   Van den Brandt, Piet A ^a   Alexandra Goldbohm, R ^f   Weijenberg, Matty P ^a   English, Dallas R ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c CANCER EPIDEMIOLOGY CENTRE   (Australia)

^d QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

^f TNO   (Netherlands)

Author keywords

Body mass index; BRAF; Cohort study; Colorectal neoplasms; Height; Microsatellite instability; Waist circumference

Indexed keywords

BODY MASS; BODY SIZE; COHORT ANALYSIS; GENETIC MARKER; HEALTH RISK; INSTABILITY; MUTATION; TUMOR;

ADULT; AGED; ARTICLE; BODY MASS; BODY SIZE; BRAF GENE; CANCER RISK; COLORECTAL CANCER; CONFIDENCE INTERVAL; FEMALE; GENE; GENE MUTATION; GENETIC ASSOCIATION; HAZARD RATIO; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE INSTABILITY; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADULT; AGED; ANTHROPOMETRY; AUSTRALIA; BODY SIZE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NETHERLANDS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PROTO-ONCOGENE PROTEINS B-RAF; QUESTIONNAIRES; REGISTRIES; RISK;

NETHERLANDS;

EID: 84864607258     PISSN: 03005771     EISSN: 14643685     Source Type: Journal    
DOI: 10.1093/ije/dys055     Document Type: Article

References (58)

1. World Cancer Research Fund/American Institute for Cancer Research. Food, Nutrition, Physical Activity, and the Prevention of Cancer: A Global Perspective. Washington DC: AIRC, 2007.
2. Noffsinger AE. Serrated polyps and colorectal cancer: new pathway to malignancy. Annu Rev Pathol 2009;4:343-64.
3. Jass JR. Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 2007;50:113-30.
4. Campbell PT, Jacobs ET, Ulrich CM et al. Case-control study of overweight, obesity, and colorectal cancer risk, overall and by tumor microsatellite instability status. J Natl Cancer Inst 2010;102:391-400.
5. Samowitz WS, Albertsen H, Herrick J et al. Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 2005;129:837-45.
6. Shen L, Toyota M, Kondo Y et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 2007;104:18654-59.
7. Toyota M, Ahuja N, Ohe-Toyota M et al. CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci U S A 1999;96:8681-86.
8. Weisenberger DJ, Siegmund KD, Campan M et al. CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer. Nat Genet 2006;38:787-93.
9. Barault L, Charon-Barra C, Jooste V et al. Hypermethylator phenotype in sporadic colon cancer: study on a population-based series of 582 cases. Cancer Res 2008;68:8541-46.
10. Ferguson LR, Karunasinghe N, Philpott M. Epigenetic events and protection from colon cancer in New Zealand. Environ Mol Mutagen 2004;44:36-43.
11. Ogino S, Chan AT, Fuchs CS et al. Molecular pathological epidemiology of colorectal neoplasia: an emerging transdisciplinary and interdisciplinary field. Gut 2011;60:397-411.
12. Ogino S, Stampfer M. Lifestyle factors and microsatellite instability in colorectal cancer: the evolving field of molecular pathological epidemiology. J Natl Cancer Inst 2010; 102:365-67.
13. Caan BJ, Coates AO, Slattery ML et al. Body size and the risk of colon cancer in a large case-control study. Int J Obes Relat Metab Disord 1998;22:178-84.
14. Slattery ML, Curtin K, Sweeney C et al. Diet and lifestyle factor associations with CpG island methylator phenotype and BRAF mutations in colon cancer. Int J Cancer 2007; 120:656-63.
15. Slattery ML, Curtin K, Wolff RK et al. Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Cancer Causes Control 2010; 21:1237-45.
16. Hughes LA, Simons CC, van den Brandt PA et al. Body size, physical activity and risk of colorectal cancer with or without the CpG Island Methylator Phenotype (CIMP). PloS One 2011;6:e18571.
17. Satia JA, Keku T, Galanko JA et al. Diet, lifestyle, and genomic instability in the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev 2005;14:429-36.
18. Pischon T, Lahmann PH, Boeing H et al. Body size and risk of colon and rectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC). J Natl Cancer Inst 2006;98:920-31.
19. Taioli E, Bonassi S. Pooled analysis of epidemiological studies involving biological markers. Int J Hyg Environ Health 2003;206:109-15.
20. Smith-Warner SA, Spiegelman D, Ritz J et al. Methods for pooling results of epidemiologic studies: the Pooling Project of Prospective Studies of Diet and Cancer. Am J Epidemiol 2006;163:1053-64.
21. Goldbohm RA, van den Brandt PA, Brants HA et al. Validation of a dietary questionnaire used in a large-scale prospective cohort study on diet and cancer. Eur J Clin Nutr 1994;48:253-65.
22. Goldbohm RA, van't Veer P, van den Brandt PA et al. Reproducibility of a food frequency questionnaire and stability of dietary habits determined from five annually repeated measurements. Eur J Clin Nutr 1995;49:420-29.
23. van den Brandt PA, Goldbohm RA, van't Veer P et al. A large-scale prospective cohort study on diet and cancer in The Netherlands. J Clin Epidemiol 1990;43:285-95.
24. van den Brandt PA, Schouten LJ, Goldbohm RA et al. Development of a record linkage protocol for use in the Dutch Cancer Registry for Epidemiological Research. Int J Epidemiol 1990;19:553-58.
25. Goldbohm RA, van den Brandt PA, Dorant E. Estimation of the coverage of municipalities by cancer registries and PALGA using hospital discharge data. Tijdschr Soc Gezondheidsz 1994;72:80-84.
26. Brink M, de Goeij AF, Weijenberg MP et al. K-ras oncogene mutations in sporadic colorectal cancer in The Netherlands Cohort Study. Carcinogenesis 2003;24:703-10.
27. Ireland P, Jolley D, Giles GG et al. Development of the Melbourne FFQ: a food frequency questionnaire for use in an Australian prospective study involving an ethnically diverse cohort. Asia Pac J Clin Nutr 1994;3:19-31.
28. Hughes LA, Schouten LJ, Goldbohm RA et al. Self-reported clothing size as a proxy measure for body size. Epidemiology 2009;20:673-76.
29. Lohman TG, Roche AF, Martorell R. Anthropometric Standardization Reference Manual. Champaign, IL: Kinetics Books, 1988.
30. Sieben NL, Roemen GM, Oosting J et al. Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants. J Pathol 2006;210:405-11.
31. Suraweera N, Duval A, Reperant M et al. Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. Gastroenterology 2002;123:1804-11.
32. Young J, Barker MA, Simms LA et al. Evidence for BRAF mutation and variable levels of microsatellite instability in a syndrome of familial colorectal cancer. Clin Gastroenterol Hepatol 2005;3:254-63.
33. Lindor NM, Burgart LJ, Leontovich O et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002;20:1043-48.
34. Korn EL, Graubard BI, Midthune D. Time-to-event analysis of longitudinal follow-up of a survey: choice of the time-scale. Am J Epidemiol 1997;145:72-80.
35. Barlow WE, Ichikawa L, Rosner D et al. Analysis of case- cohort designs. J Clin Epidemiol 1999;52:1165-72.
36. Lunn M, McNeil D. Applying Cox regression to competing risks. Biometrics 1995;51:524-32.
37. English DR, Young JP, Simpson JA et al. Ethnicity and risk for colorectal cancers showing somatic BRAF V600E mutation or CpG island methylator phenotype. Cancer Epidemiol Biomarkers Prev 2008;17:1774-80.
38. de Vogel S, Bongaerts BW, Wouters KA et al. Associations of dietary methyl donor intake with MLH1 promoter hypermethylation and related molecular phenotypes in sporadic colorectal cancer. Carcinogenesis 2008;29:1765-73.
39. de Vogel S, Weijenberg MP, Herman JG et al. MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events. Ann Oncol 2009;20: 1216-22.
40. de Vogel S, Wouters KA, Gottschalk RW et al. Genetic variants of methyl metabolizing enzymes and epigenetic regulators: associations with promoter CpG island hypermethylation in colorectal cancer. Cancer Epidemiol Biomarkers Prev 2009;18:3086-96.
41. Bolton-Smith C, Woodward M, Tunstall-Pedoe H et al. Accuracy of the estimated prevalence of obesity from self reported height and weight in an adult Scottish population. J Epidemiol Community Health 2000;54:143-48.
42. Nyholm M, Gullberg B, Merlo J et al. The validity of obesity based on self-reported weight and height: implications for population studies. Obesity;15:197-208.
43. Spencer EA, Appleby PN, Davey GK et al. Validity of self-reported height and weight in 4808 EPIC-Oxford participants. Public Health Nutr 2002;5:561-65.
44. Wada K, Tamakoshi K, Tsunekawa T et al. Validity of self-reported height and weight in a Japanese workplace population. Int J Obes 2005;29:1093-99.
45. Gordon I, Boffetta P, Demers PA. A case study comparing a meta-analysis and a pooled analysis of studies of sinonasal cancer among wood workers. Epidemiology 1998;9:518-24.
46. Slattery ML, Curtin K, Anderson K et al. Associations between cigarette smoking, lifestyle factors, and microsatellite instability in colon tumors. J Natl Cancer Inst 2000;92: 1831-36.
47. Smits KM, Cleven AH, Weijenberg MP et al. Pharmacoepigenomics in colorectal cancer: a step forward in predicting prognosis and treatment response. Pharmacogenomics 2008;9:1903-16.
48. Imai K, Yamamoto H. Carcinogenesis and microsatellite instability: the interrelationship between genetics and epigenetics. Carcinogenesis 2008;29:673-80.
49. Hughes LA, Khalid-de Bakker CA, Smits KM et al. The CpG island methylator phenotype in colorectal cancer: progress and problems. Biochim Biophys Acta 2012;1825: 77-85.
50. Hinoue T, Weisenberger DJ, Lange CP et al. Genome-scale analysis of aberrant DNA methylation in colorectal cancer. Genome Res 2012;22:271-82.
51. Ogino S, Kawasaki T, Kirkner GJ et al. CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations. J Mol Diagn 2006;8:582-88.
52. Yagi K, Akagi K, Hayashi H et al. Three DNA methylation epigenotypes in human colorectal cancer. Clin Cancer Res 2010;16:21-33.
53. Dirx MJ, van den Brandt PA, Goldbohm RA et al. Energy restriction early in life and colon carcinoma risk: results of The Netherlands Cohort Study after 7.3 years of follow-up. Cancer 2003;97:46-55.
54. Frankel S, Gunnell DJ, Peters TJ et al. Childhood energy intake and adult mortality from cancer: the Boyd Orr Cohort Study. BMJ 1998;316:499-504.
55. Hughes LA, van den Brandt PA, Goldbohm RA et al. Childhood and adolescent energy restriction and subsequent colorectal cancer risk: results from The Netherlands Cohort Study. Int J Epidemiol 2010;39:1333-44.
56. Svensson E, Grotmol T, Hoff G et al. Trends in colorectal cancer incidence in Norway by gender and anatomic site: an age-period-cohort analysis. Eur J Cancer Prev 2002;11: 489-95.
57. Svensson E, Moller B, Tretli S et al. Early life events and later risk of colorectal cancer: age-period-cohort modelling in the Nordic countries and Estonia. Cancer Causes Control 2005;16:215-23.
58. Hughes LA, van den Brandt PA, de Bruine AP et al. Early life exposure to famine and colorectal cancer risk: a role for epigenetic mechanisms. PloS One 2009;4:e7951.